伊诺利他宗

Inolitazone

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
1mg 98% 询价
- +
5mg 98% 询价
- +
10mg 98% 询价
- +
25mg 98% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

223132-37-4

中文名称

伊诺利他宗

英文名称

Inolitazone

别名

UNII-M17ILL71MC | CHEBI:168130 | FT-0737589 | 5-[4-[6-(4-amino-3 ,5-dimethylphenoxy)-1-methyl-1H-benzimidazol-2-ylmethoxy]benzyl]thiazolidine-2,4-dione | Q21083321 | BDBM50450236 | (cis) 3,3,5-trimethylcyclohexanol | 5-(4-{[6-(4-amino-3,5-dimethylphenoxy)

标准英文名

Inolitazone

MDL No.

MFCD18633242

分子式

C27H26N4O4S

分子量

502.60

精确分子量

502.17

SMILES

O=C(N1)SC(CC2=CC=C(OCC3=NC4=CC=C(OC5=CC(C)=C(N)C(C)=C5)C=C4N3C)C=C2)C1=O

标准SMILES

CN1C2=CC(=CC=C2N=C1COC1C=CC(CC2SC(=O)NC2=O)=CC=1)OC1C=C(C)C(N)=C(C)C=1

用途

Inolitazone (RS5444; CS-7017) is a novel high-affinity PPARγ agonist with potential antiproliferative and antitumor activities; it inhibits tumor growth in xenograft models of anaplastic thyroid carcinoma (ATC) in a dose-dependent manner; it demonstrates additive antiproliferative effects when combined with paclitaxel in vitro; it upregulates the cell cycle kinase inhibitor p21WAF1/CIP1 in a PPARγ-dependent manner; it suppresses DRO and ARO tumor growth in vivo when administered orally in diet after tumor establishment.

InChIKey

JCYNMRJCUYVDBC-UHFFFAOYSA-N

安全信息

SureRoute逆合成路线

1.  223132-37-4 逆合成路线 1

—
—
—
—
ACDTQJ324
7447-41-8
ACKTWI481
223132-37-4
来源: SureRoute

2.  223132-37-4 逆合成路线 2

—
—
ACKTWI481
223132-37-4
来源: SureRoute

3.  223132-37-4 逆合成路线 3

—
—
ACKTWI481
223132-37-4
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手